Barriers to Diagnosis and Treatment of Postpartum Depression: A Global PerspectiveAug 21, 2025·5 min read
Partner Support and Mental Health Outcomes in Postpartum DepressionIntroduction Postpartum depression (PPD) is one of the most prevalent complications of childbirth, affecting a substantial number of women worldwide within the first year after delivery. It not only undermines maternal well-being but also disrupts th...Aug 25, 2025·5 min read
CRISPR and Gene Therapy: Transforming Biogenetic Research into Clinical ApplicationsAug 6, 2025·4 min read
Novel Biomarkers in the Early Detection and Monitoring of Kidney DiseaseIntroduction Chronic kidney disease (CKD) affects over 800 million people worldwide and represents a growing global health burden. Early detection and accurate monitoring are crucial for improving outcomes, slowing disease progression, and preventing...Jul 24, 2025·4 min read
Targeting Amyloid and Tau Proteins: Current and Emerging Therapies for Alzheimer’sAlzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, cognitive impairment, and functional decline. The pathophysiology of AD is largely associated with two hallmark proteins: amyloid-beta (Aβ) and tau. Aβ...Jul 16, 2025·4 min read
Early Diagnosis of Alzheimer’s: Advances in Biomarkers and Imaging TechniquesAlzheimer’s disease (AD) is a progressive neurodegenerative disorder that remains one of the leading causes of disability and death among older adults. Traditionally diagnosed based on clinical symptoms and cognitive decline, Alzheimer’s is now incre...Jul 10, 2025·4 min read
Innovative Treatments Rooted in Biogenomics: A New Era for SMA, Alzheimer’s, and DepressionBiogenomics—the study of the complex relationships between genes and biological processes—has emerged as a transformative force in modern medicine. Its promise lies in enabling treatments tailored to the genetic architecture underlying disease. Spina...Jul 3, 2025·4 min read
Spinal Muscular Atrophy and Kidney Function: Biogen’s Role in Systemic TherapeuticsIntroduction Spinal Muscular Atrophy (SMA) is a genetic neuromuscular disorder characterized by the degeneration of motor neurons in the spinal cord and brainstem. This degeneration leads to progressive muscle wasting, weakness, and in severe cases, ...Jun 25, 2025·5 min read
Unified Therapeutic Models for Neurodegeneration, SMA, and Renal DisordersThe convergence of therapeutic strategies across seemingly distinct diseases has become a burgeoning area of interest in biomedical research. Neurodegenerative diseases, Spinal Muscular Atrophy (SMA), and renal disorders, despite affecting different ...Jun 19, 2025·4 min read
